Penumbra Inc (PEN): Next-Year EPS Estimate 25.34%
As of 2026-06-11, Penumbra Inc (PEN) has a next-year EPS growth estimate of 25.34%.
On 2026-06-10, analyst consensus for PEN's next-year EPS growth shifted from 25.94% to 25.34% — a negative change of 0.60 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 28.26%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 25.34%
- EPS growth this year
- 28.26%
- EPS next quarter (est)
- $1.17
- Last price
- $318.32
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 25.34% | 28.26% | $1.17 | $318.32 |
| 2026-06-10 | 25.34% | 28.26% | $1.17 | $319.34 |
| 2026-04-24 | 25.94% | 29.43% | $1.04 | $329.89 |
| 2026-04-23 | 26.46% | 30.24% | $1.06 | $333.00 |
| 2026-04-22 | 26.46% | 30.24% | $1.06 | $332.21 |
| 2026-04-21 | 26.46% | 30.24% | $1.06 | $327.00 |
| 2026-04-20 | 26.46% | 30.24% | $1.06 | $329.71 |
| 2026-04-19 | 26.46% | 30.24% | $1.06 | $332.13 |
| 2026-04-16 | 26.46% | 30.24% | $1.06 | $331.47 |
| 2026-04-15 | 26.46% | 30.24% | $1.06 | $332.42 |
| 2026-04-14 | 26.46% | 30.24% | $1.06 | $332.17 |
| 2026-04-13 | 26.46% | 30.24% | $1.06 | $331.48 |
| 2026-04-12 | 26.39% | 30.41% | $1.06 | $329.77 |
| 2026-04-10 | 26.39% | 30.41% | $1.06 | $329.32 |
| 2026-04-09 | 26.39% | 30.41% | $1.06 | $329.52 |
| 2026-04-08 | 26.39% | N/A | $1.06 | $331.08 |
| 2026-04-07 | 26.39% | N/A | $1.06 | $329.96 |
| 2026-04-06 | 26.39% | N/A | $1.06 | $329.96 |
| 2026-04-05 | 26.39% | N/A | $1.06 | $330.36 |
| 2026-04-03 | 26.39% | N/A | $1.06 | $329.96 |
| 2026-04-02 | 26.39% | N/A | $1.06 | $329.96 |
| 2026-04-01 | 26.39% | N/A | $1.06 | $329.96 |
| 2026-04-01 | 26.39% | N/A | N/A | $328.96 |
| 2026-04-01 | 26.39% | N/A | N/A | $328.96 |
| 2026-04-01 | 26.39% | N/A | N/A | $328.96 |
| 2026-03-31 | 26.39% | N/A | N/A | $328.37 |
| 2026-03-31 | 26.39% | N/A | N/A | $328.37 |
| 2026-03-31 | 26.39% | N/A | N/A | $328.37 |
| 2026-03-30 | 26.39% | N/A | N/A | $328.20 |
| 2026-03-30 | 26.39% | N/A | N/A | $328.20 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Penumbra Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Penumbra Inc (PEN) has a next-year EPS growth estimate of 25.34%, based on analyst consensus.
When was the latest EPS estimate revision for PEN?▾
The most recent revision occurred on 2026-06-10, when analysts adjusted the next-year EPS growth estimate from 25.94% to 25.34%.
What sector and industry does Penumbra Inc belong to?▾
Penumbra Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PEN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Penumbra Inc (PEN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports